X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2857229/0/en/AB-Science-announces-that-Health-Canada-has-granted-eligibility-for-reconsideration-request-for-masitinib-in-ALS.html
https://www.globenewswire.com//news-release/2024/03/13/2845340/0/en/AB-Science-New-research-shows-that-masitinib-limits-neuronal-damage-in-a-model-of-neuroimmune-driven-neurodegenerative-disease.html
https://www.globenewswire.com//news-release/2024/03/07/2842341/0/en/AB-Science-provides-a-summary-of-the-live-webcast-held-on-March-4-2024-giving-an-update-on-AB-Science-development.html
https://www.globenewswire.com//news-release/2024/03/06/2841727/0/en/AB-Science-announces-that-two-financial-analysis-firms-DNA-Finance-and-In-Extenso-Finance-have-initiated-coverage-of-the-Company.html
https://www.globenewswire.com//news-release/2024/03/01/2839001/0/en/AB-Science-will-host-a-live-webcast-on-Monday-March-4-2024-from-6-30pm-to-7-30pm-CET.html
https://www.globenewswire.com//news-release/2024/02/29/2837748/0/en/AB-Science-will-host-a-live-webcast-on-Monday-March-4-2024-from-6-30pm-to-7-30pm-CET.html
https://www.globenewswire.com//news-release/2024/02/26/2835372/0/en/AB-Science-announces-that-Health-Canada-has-issued-a-Notice-of-Non-Compliance-Withdrawal-NON-w-for-masitinib-in-ALS.html
https://www.globenewswire.com//news-release/2024/01/26/2818214/0/en/AB-Science-announces-an-update-in-the-marketing-authorization-application-of-masitinib-in-amyotrophic-lateral-sclerosis-at-the-European-Medicines-Agency.html
https://www.globenewswire.com//news-release/2024/01/15/2809319/0/en/AB-Science-receives-notice-of-allowance-for-European-patent-covering-masitinib-until-2036-in-the-treatment-of-mastocytosis.html
https://www.globenewswire.com//news-release/2023/11/28/2787283/0/en/AB-Science-will-host-a-live-webcast-on-Thursday-November-30-2023-from-3pm-to-4pm-CET-to-present-the-masitinib-development-program-in-sickle-cell-disease.html
Market Place
Share 
